NRIX
Nurix Therapeutics Inc
NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY
$25.10
-2.75% today
Updated 2026-09-11
Market cap
$2.73B
P/E ratio
—
P/S ratio
74.13x
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$8 – $28
Volume
1.2M
Nurix Therapeutics Inc (NRIX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$25.10
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$11.83
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.